Journal ArticleDOI
Nonviral Vectors for Gene Delivery
TLDR
Two nonviral gene delivery systems using either biodegradable poly(D,Llactide-co-glycolide) (PLG) nanoparticles or cell penetrating peptide (CPP) complexes have been designed and studied using A549 human lung epithelial cells.Abstract:
The development of nonviral vectors for safe and efficient gene delivery has been gaining considerable attention recently. An ideal nonviral vector must protect the gene against degradation by nuclease in the extracellular matrix, internalize the plasma membrane, escape from the endosomal compartment, unpackage the gene at some point and have no detrimental effects. In comparison to viruses, nonviral vectors are relatively easy to synthesize, less immunogenic, low in cost, and have no limitation in the size of a gene that can be delivered. Significant progress has been made in the basic science and applications of various nonviral gene delivery vectors; however, the majority of nonviral approaches are still inefficient and often toxic. To this end, two nonviral gene delivery systems using either biodegradable poly(D,Llactide-co-glycolide) (PLG) nanoparticles or cell penetrating peptide (CPP) complexes have been designed and studied using A549 human lung epithelial cells. PLG nanoparticles were optimized for gene delivery by varying particle surface chemistry using different coating materials that adsorb to the particle surface during formation. A variety of cationic coating materials were studied and compared to more conventional surfactants used for PLG nanoparticle fabrication. Nanoparticles (~200 nm) efficiently encapsulated plasmids encoding for luciferase (80-90%) and slowly released the same for two weeks. After a delay, moderate levels of gene expression appeared at day 5 for certain positively charged PLG particles and gene expression was maintained for at least two weeks. In contrast, gene expression mediated by polyethyleneimine (PEI) ended at day 5. PLG particles were also significantly lessread more
Citations
More filters
Journal ArticleDOI
Non-viral vectors for gene-based therapy
Hao Yin,Rosemary Lynn Kanasty,Ahmed A. Eltoukhy,Arturo J. Vegas,J. Robert Dorkin,Daniel G. Anderson +5 more
TL;DR: The biological barriers to gene delivery in vivo are introduced and recent advances in material sciences, nanotechnology and nucleic acid chemistry that have yielded promising non-viral delivery systems are discussed, some of which are currently undergoing testing in clinical trials.
Journal ArticleDOI
Functionalizing nanoparticles with biological molecules: developing chemistries that facilitate nanotechnology.
Kim E. Sapsford,W. Russ Algar,Lorenzo Berti,Kelly Boeneman Gemmill,Brendan J. Casey,Eunkeu Oh,Michael H. Stewart,Igor L. Medintz +7 more
TL;DR: Chemistries that Facilitate Nanotechnology Kim E. Sapsford,† W. Russ Algar, Lorenzo Berti, Kelly Boeneman Gemmill,‡ Brendan J. Casey,† Eunkeu Oh, Michael H. Stewart, and Igor L. Medintz .
Journal ArticleDOI
Nanochemistry and Nanomedicine for Nanoparticle-based Diagnostics and Therapy
TL;DR: This work presents a new generation of high-performance liquid chromatography platforms for selective separation of Na6(CO3) from Na4(SO4) through Na2SO4 and shows real-world applications in drug discovery and treatment of central nervous system disorders.
Journal ArticleDOI
Stimuli-responsive polymeric nanocarriers for the controlled transport of active compounds: Concepts and applications ☆
TL;DR: This review gives a brief overview about some types of stimuli-responsive nanocarriers with the main focus on organic polymer-based systems.
Journal ArticleDOI
Mesoporous Silica Nanoparticles for Intracellular Controlled Drug Delivery
TL;DR: The latest research on the pathways of entry into live mammalian and plant cells together with intracellular trafficking are described, and the current research progress on the biocompatibility of this material in vitro and in vivo is discussed.
References
More filters
Journal ArticleDOI
A powerful nonviral vector for in vivo gene transfer into the adult mammalian brain : polyethylenimine
Bassima Abdallah,Ahmed Hassan,Corinne Benoist,Daniel Goula,Jean-Paul Behr,Barbara A. Demeneix +5 more
TL;DR: It is shown that the cationic polymer polyethylenimine (PEI) provides unprecedentedly high levels of transgene expression in the mature mouse brain and appears to have potential for fundamental research and genetic therapy of the brain.
Journal ArticleDOI
A new peptide vector for efficient delivery of oligonucleotides into mammalian cells
TL;DR: This new strategy of oligonucleotide delivery into cultured cells based on a peptide vector offers several advantages compared to other commonly used approaches of delivery including efficiency, stability and absence of cytotoxicity, and is proposed as a powerful tool for potential development in gene and antisense therapy.
Journal ArticleDOI
A triploblast origin for Myxozoa
TL;DR: The presence of Hox class genes that are typical of triploblasts in Myxozoa is reported, which confirms MyXozoa's phylogenetic affinity with the Bilateria and reveals an extreme example of parasitic degeneracy.
Journal ArticleDOI
T Cell-Specific siRNA Delivery Suppresses HIV-1 Infection in Humanized Mice
Priti Kumar,Hong Seok Ban,Sang-Soo Kim,Haoquan Wu,Todd Pearson,Dale L. Greiner,Amale Laouar,Jiahong Yao,Viraga Haridas,Katsuyoshi Habiro,Yong-Guang Yang,Ji Hoon Jeong,Kuen Yong Lee,Yong-Hee Kim,Sung Wan Kim,Matthias Peipp,Georg H. Fey,N. Manjunath,Leonard D. Shultz,Sang-Kyung Lee,Premlata Shankar +20 more
TL;DR: SiRNA therapy for HIV infection appears to be feasible in a preclinical animal model and could deliver antiviral siRNAs to naive T cells in Hu-HSC mice and effectively suppress viremia in infected mice.
Journal ArticleDOI
Size-dependency of nanoparticle-mediated gene transfection: studies with fractionated nanoparticles.
TL;DR: The results suggest that the particle size is an important factor, and that the smaller-sized fraction of the nanoparticle formulation predominantly contributes towards their transfection.